Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care.
about
Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Drug concentrations and anti-d ...... imab (CT-P13) in routine care.
@en
Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab
@nl
type
label
Drug concentrations and anti-d ...... imab (CT-P13) in routine care.
@en
Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab
@nl
prefLabel
Drug concentrations and anti-d ...... imab (CT-P13) in routine care.
@en
Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab
@nl
P2093
P2860
P50
P1476
Drug concentrations and anti-d ...... imab (CT-P13) in routine care.
@en
P2093
A Linauskas
B Glintborg
C H Nielsen
D J Warren
D V Jensen
H Lindegaard
I J Sørensen
P2860
P304
P356
10.1080/03009742.2017.1376110
P577
2018-01-09T00:00:00Z